|
2020 July 29 |
Altered glycosylation in pancreatic cancer: development of new tumor markers and therapeutic strategies |
Guerrero Barrado, Pedro Enrique
|
|
|
2018 September |
Biomarcadors moleculars no invasius pel cĂ ncer de pĂ ncrees |
Mattioli Borrull, Romana
|
|
|
2004 March 19 |
GlicosilaciĂł aberrant en proteĂŻnes de secreciĂł com a marcadors tumorals |
Tabarés Carreras, Glòria
|
|
|
GlicosilaciĂł aberrant en proteĂŻnes de secreciĂł com a marcadors tumorals |
Tabarés Carreras, Glòria
|
|
|
2011 February 10 |
Glycan alterations of serum proteins as tumour markers. Prostate-specific antigen in prostate cancer and acute-phase proteins in pancreatic cancer |
Sarrats CarbĂł, Ariadna
|
|
|
|
Glycan alterations of serum proteins as tumour markers. Prostate-specific antigen in prostate cancer and acute-phase proteins in pancreatic cancer |
Sarrats CarbĂł, Ariadna
|
|
|
2017 September |
Glycomic and glycoproteomic approaches :|bpotential tools for the improvement of the gold standard biomarker for prostate cancer diagnosis |
Domènech GarcĂa, Heura
|
|
|
|
Identification of potential pancreatic cancer serum markers: Increased sialyl-Lewis X on ceruloplasmin |
Balmaña, Meritxell
; Sarrats CarbĂł, Ariadna
; Llop Escorihuela, Esther
; BarrabĂ©s Vera, SĂlvia
; Saldova, Radka
; Ferri Iglesias, MarĂa JosĂ©
; Figueras, Joan
; Fort Martorell, Esther
; Llorens Duran, Rafael de
; Rudd, Pauline M.
; Peracaula MirĂł, Rosa
|
|
|
2015 March |
Identification of potential pancreatic cancer serum markers: Increased sialyl-Lewis X on ceruloplasmin |
Balmaña, Meritxell
; Sarrats CarbĂł, Ariadna
; Llop Escorihuela, Esther
; BarrabĂ©s Vera, SĂlvia
; Saldova, Radka
; Ferri Iglesias, MarĂa JosĂ©
; Figueras, Joan
; Fort Martorell, Esther
; Llorens Duran, Rafael de
; Rudd, Pauline M.
; Peracaula MirĂł, Rosa
|
|
|
|
Improved Pancreatic Adenocarcinoma Diagnosis in Jaundiced and Non-Jaundiced Pancreatic Adenocarcinoma Patients through the Combination of Routine Clinical Markers Associated to Pancreatic Adenocarcinoma Pathophysiology |
Ferri Iglesias, MarĂa JosĂ©
; Sáez Zafra, Marc
; Figueras, Joan
; Fort Martorell, Esther
; SĂ bat Mir, MĂriam
; LĂłpez-Ben, Santiago
; Llorens Duran, Rafael de
; Aleixandre i Cerarols, Rosa NĂşria
; Peracaula MirĂł, Rosa
|
|
|
2018 June 1 |
Improved Pancreatic Adenocarcinoma Diagnosis in Jaundiced and Non-Jaundiced Pancreatic Adenocarcinoma Patients through the Combination of Routine Clinical Markers Associated to Pancreatic Adenocarcinoma Pathophysiology |
|
|
|
2018 June 5 |
Improved Pancreatic Adenocarcinoma Diagnosis in Jaundiced and Non-Jaundiced Pancreatic Adenocarcinoma Patients through the Combination of Routine Clinical Markers Associated to Pancreatic Adenocarcinoma Pathophysiology |
Ferri Iglesias, MarĂa JosĂ©
; Sáez Zafra, Marc
; Figueras, Joan
; Fort Martorell, Esther
; SĂ bat Mir, MĂriam
; LĂłpez-Ben, Santiago
; Llorens Duran, Rafael de
; Aleixandre i Cerarols, Rosa NĂşria
; Peracaula MirĂł, Rosa
|
|
|
2016 January 25 |
Improved Pancreatic Adenocarcinoma Diagnosis in Jaundiced and Non-Jaundiced Pancreatic Adenocarcinoma Patients through the Combination of Routine Clinical Markers Associated to Pancreatic Adenocarcinoma Pathophysiology |
Ferri Iglesias, MarĂa JosĂ©
; Sáez Zafra, Marc
; Figueras, Joan
; Fort Martorell, Esther
; SĂ bat Mir, MĂriam
; LĂłpez-Ben, Santiago
; Llorens Duran, Rafael de
; Aleixandre i Cerarols, Rosa NĂşria
; Peracaula MirĂł, Rosa
|
|
|
2020 February 15 |
Improved Pancreatic Adenocarcinoma Diagnosis in Jaundiced and Non-Jaundiced Pancreatic Adenocarcinoma Patients through the Combination of Routine Clinical Markers Associated to Pancreatic Adenocarcinoma Pathophysiology |
Ferri Iglesias, MarĂa JosĂ©
; Sáez Zafra, Marc
; Figueras, Joan
; Fort Martorell, Esther
; SĂ bat Mir, MĂriam
; LĂłpez-Ben, Santiago
; Llorens Duran, Rafael de
; Aleixandre i Cerarols, Rosa NĂşria
; Peracaula MirĂł, Rosa
|
|
|
|
Increased α1-3 fucosylation of α-1-acid glycoprotein (AGP) in pancreatic cancer |
Balmaña, Meritxell
; Giménez, Estela
; Puerta, Angel
; Llop Escorihuela, Esther
; Figueras, Joan
; Fort Martorell, Esther
; Sanz Nebot, MarĂa Victoria
; Bolòs, Carme de
; Rizzi, Andreas
; BarrabĂ©s Vera, SĂlvia
; Frutos, Mercedes de
; Peracaula MirĂł, Rosa
|
|
|
2016 January 30 |
Increased α1-3 fucosylation of α-1-acid glycoprotein (AGP) in pancreatic cancer |
Balmaña, Meritxell
; Giménez, Estela
; Puerta, Angel
; Llop Escorihuela, Esther
; Figueras, Joan
; Fort Martorell, Esther
; Sanz Nebot, MarĂa Victoria
; Bolòs, Carme de
; Rizzi, Andreas
; BarrabĂ©s Vera, SĂlvia
; Frutos, Mercedes de
; Peracaula MirĂł, Rosa
|
|
|
|
Interferon/STAT1 and neuregulin signaling pathways are exploratory biomarkers of cetuximab (Erbitux®) efficacy in KRAS wild-type squamous carcinomas: A pathway-based analysis of whole human-genome microarray data from cetuximab-adapted tumor cell-line models |
Oliveras FerrarĂłs, Cristina
; Vázquez MartĂn, Alejandro
; Queralt, Bernardo
; Adrados, Manuel
; Ortiz, Rosa
; CufĂ González, SĂlvia
; Hernández Yagüe, Xavier
; Guardeño, Raquel
; Báez, Luciana
; Martin Castillo, Begoña
; PĂ©rez MartĂnez, Maria Carmen
; LĂłpez Bonet, Eugeni
; Llorens Duran, Rafael de
; BernadĂł, Luis
; Brunet i Vidal, Joan
; Menéndez Menéndez, Javier Abel
|
|
|
|
Interferon/STAT1 and neuregulin signaling pathways are exploratory biomarkers of cetuximab (Erbitux®) efficacy in KRAS wild-type squamous carcinomas: A pathway-based analysis of whole human-genome microarray data from cetuximab-adapted tumor cell-line models |
Oliveras FerrarĂłs, Cristina
; Vázquez MartĂn, Alejandro
; Queralt, Bernardo
; Adrados, Manuel
; Ortiz, Rosa
; CufĂ González, SĂlvia
; Hernández Yagüe, Xavier
; Guardeño, Raquel
; Báez, Luciana
; Martin Castillo, Begoña
; PĂ©rez MartĂnez, Maria Carmen
; LĂłpez Bonet, Eugeni
; Llorens Duran, Rafael de
; BernadĂł, Luis
; Brunet i Vidal, Joan
; Menéndez Menéndez, Javier Abel
|
|
|
2018 June 1 |
Interferon/STAT1 and neuregulin signaling pathways are exploratory biomarkers of cetuximab (Erbitux®) efficacy in KRAS wild-type squamous carcinomas: A pathway-based analysis of whole human-genome microarray data from cetuximab-adapted tumor cell-line models |
|
|
|
2018 June 5 |
Interferon/STAT1 and neuregulin signaling pathways are exploratory biomarkers of cetuximab (Erbitux®) efficacy in KRAS wild-type squamous carcinomas: A pathway-based analysis of whole human-genome microarray data from cetuximab-adapted tumor cell-line models |
Oliveras FerrarĂłs, Cristina
; Vázquez MartĂn, Alejandro
; Queralt, Bernardo
; Adrados, Manuel
; Ortiz, Rosa
; CufĂ González, SĂlvia
; Hernández Yagüe, Xavier
; Guardeño, Raquel
; Báez, Luciana
; Martin Castillo, Begoña
; PĂ©rez MartĂnez, Maria Carmen
; LĂłpez Bonet, Eugeni
; Llorens Duran, Rafael de
; BernadĂł, Luis
; Brunet i Vidal, Joan
; Menéndez Menéndez, Javier Abel
|
|
|
2011 |
Interferon/STAT1 and neuregulin signaling pathways are exploratory biomarkers of cetuximab (Erbitux®) efficacy in KRAS wild-type squamous carcinomas: A pathway-based analysis of whole human-genome microarray data from cetuximab-adapted tumor cell-line models |
Oliveras FerrarĂłs, Cristina
; Vázquez MartĂn, Alejandro
; Queralt, Bernardo
; Adrados, Manuel
; Ortiz Duran, Maria Rosa
; CufĂ González, SĂlvia
; Hernández Yagüe, Xavier
; Guardeño, Raquel
; Báez, Luciana
; Martin Castillo, Begoña
; PĂ©rez MartĂnez, Maria Carmen
; LĂłpez Bonet, Eugeni
; Llorens Duran, Rafael de
; BernadĂł, Luis
; Brunet i Vidal, Joan
; Menéndez Menéndez, Javier Abel
|
|
|
2016 June |
ModelitzaciĂł de les diverses glicoformes de l’antigen prostĂ tic especĂfic (PSA) |
Palomanes Jimenez, Aitor
|
|
|
|
ModelitzaciĂł de les diverses glicoformes de l’antigen prostĂ tic especĂfic (PSA) |
Palomanes Jimenez, Aitor
|
|
|
2012 September 27 |
MolĂ©culas sĂ©ricas relacionadas con la fisiopatologĂa del adenocarcinoma pancreático como posibles marcadores tumorales |
Ferri Iglesias, MarĂa JosĂ©
|
|
|
|
MolĂ©culas sĂ©ricas relacionadas con la fisiopatologĂa del adenocarcinoma pancreático como posibles marcadores tumorales |
Ferri Iglesias, MarĂa JosĂ©
|
